Study on early-onset benign occipital seizure susceptibility syndrome

Area of Science:

• Pediatric Neurology
• Epileptology
• Clinical Neuroscience

Background:

• Early-onset epilepsy requires accurate diagnosis to predict prognosis.
• Benign occipital seizure susceptibility syndrome is a recognized epilepsy syndrome in children.
• Confirming the benign nature of this syndrome is crucial for clinical management.

Purpose of the Study:

• To prospectively evaluate the long-term prognosis of early-onset benign occipital seizure susceptibility syndrome.
• To confirm the benign prognosis and identify factors influencing seizure course.
• To analyze clinical characteristics, treatment response, and EEG findings.

Main Methods:

• Prospective study of 37 children meeting specific diagnostic criteria for benign occipital seizure susceptibility syndrome.
• Inclusion criteria: normal development pre-epilepsy, onset 1-8 years, normal brain imaging, specific seizure semiology (ictal vomiting, tonic eye-deviations), and normal EEG background.
• Follow-up for over 2 years, analyzing seizure frequency, treatment response, and EEG data.

Main Results:

• Seizure frequency varied, with a median of five seizures per child.
• 15 children experienced recurrent prolonged seizures initially resistant to antiepileptic drugs.
• At final follow-up, 28 patients (76%) were seizure-free for at least 2 years, with remission by age 12.
• Occipital EEG foci were common, with a later shift in predominant foci observed in some cases.

Conclusions:

• Early-onset benign occipital seizure susceptibility syndrome generally has a benign prognosis.
• While some children present with severe, drug-resistant seizures, most achieve long-term remission.
• The syndrome's clinical spectrum ranges from mild to severe, but ultimate remission by adolescence is typical.